Skip to main content
RAPS Euro Convergence 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Expert
Learning Level: Expert
Learning Level: Foundational
Learning Level: Foundational
Learning Level: Intermediate
Learning Level: Intermediate
RAPS Focus
RAPS Focus
Networking Opportunity
Networking Opportunity
Ticketed Event
Ticketed Event
Student Focus
Student Focus

Mohamad Toutounji, Ph.D (he/him/his)

CMC Scientist
Molgenium
Düsseldorf, Nordrhein-Westfalen, Germany

Dr. Mohamad Toutounji is an accomplished scientist and consultant specializing in Advanced Therapy Medicinal Products (ATMPs), CMC strategy, and analytical development for biologics and cell/gene therapies. He holds a Ph.D. in Biochemistry from the University of Veterinary Medicine Hannover, Germany.

With over 10 years of experience in pharmaceutical development, Dr. Toutounji has held senior roles at leading organizations including Sanofi, Lonza, and GE Healthcare, where he contributed to GMP compliance, tech transfer, and late-phase manufacturing readiness. His expertise spans mRNA platforms, radiopharmaceuticals, and biologics, supported by a strong foundation in regulatory documentation (IND/NDA) and quality systems.

Dr. Toutounji combines scientific rigor with process optimization to drive innovation in advanced therapies. His career reflects a unique blend of research excellence, industrial leadership, and regulatory expertise, making him a recognized voice in the evolving landscape of biopharmaceutical development.

Presentation(s):